Volume 3; Issue 6

Expert Opinion on Drug Safety

Volume 3; Issue 6
1

Risk–benefit effects of tocolytic therapy

Année:
2004
Langue:
english
Fichier:
PDF, 209 KB
english, 2004
2

Rosuvastatin safety: lessons from the FDA review and post-approval surveillance

Année:
2004
Langue:
english
Fichier:
PDF, 175 KB
english, 2004
3

Arsenic trioxide in the treatment of haematological malignancies

Année:
2004
Langue:
english
Fichier:
PDF, 114 KB
english, 2004
4

Mucocutaneous side effects of antineoplastic chemotherapy

Année:
2004
Langue:
english
Fichier:
PDF, 136 KB
english, 2004
5

Impact of phenytoin therapy on the skin and skin disease

Année:
2004
Langue:
english
Fichier:
PDF, 138 KB
english, 2004
6

Risks of testosterone replacement therapy in ageing men

Année:
2004
Langue:
english
Fichier:
PDF, 104 KB
english, 2004
7

Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity

Année:
2004
Langue:
english
Fichier:
PDF, 75 KB
english, 2004
8

Chemotherapy-induced peripheral neurotoxicity

Année:
2004
Langue:
english
Fichier:
PDF, 139 KB
english, 2004
11

Safety of drotrecogin alfa (activated) in the treatment of patients with severe sepsis

Année:
2004
Langue:
english
Fichier:
PDF, 149 KB
english, 2004
12

The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa)

Année:
2004
Langue:
english
Fichier:
PDF, 97 KB
english, 2004
13

Disturbance of vision by COX-2 inhibitors

Année:
2004
Langue:
english
Fichier:
PDF, 95 KB
english, 2004